Disposition and tissue distribution of boron after infusion of borocaptate sodium in patients with malignant brain tumors

International Journal of Radiation Oncology Biology Physics

Volumn 41, Issue 3, 1998, Pages 631-638

  Horn, Vladimír ^d   Pharm, D ^a   Slánský, Josef ^a   Janku, Ivo ^a   Štrouf, Oldřich ^b   Šourek, Karel ^c   Tovaryš, František ^c  

^a INSTITUTE OF MATHEMATICS   (Czech Republic)

^b INSTITUTE OF INORGANIC CHEMISTRY   (Czech Republic)

^c NA HOMOLCE HOSPITAL   (Czech Republic)

^d NONE

Author keywords

BNCT; BSH biodistribution; BSH pharmacokinetics; BSH side effects; Malignant: cerebral tumors

Indexed keywords

BOROCAPTATE; BORON 10;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DRUG DISPOSITION; DRUG HALF LIFE; GLIOBLASTOMA; HUMAN; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

ADULT; BOROHYDRIDES; BORON; BORON NEUTRON CAPTURE THERAPY; FEMALE; HALF-LIFE; HUMANS; MALE; MIDDLE AGED; SULFHYDRYL COMPOUNDS; TISSUE DISTRIBUTION;

EID: 0344906209     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00069-8     Document Type: Article

References (29)

1. Buchar E., Bednářová S., Grüner B., Walder P., Štrouf O., Janků I. Dose-dependent disposition kinetics and tissue accumulation of boron after intravenous injection of sodium mercaptoundecahydrododecaborate in rabbits. Cancer Chemother. Pharmacol. 29:1992;450-454.
2. Gregoire V., Begg A.C., Huiskamp R., Verrijk R., Bartelink H. Selectivity of boron carriers for boron neutron capture therapy Pharmacological studies with borocaptate sodium, L-borophenylalanine and boric acid in murine tumors . Radiother. Oncol. 27:1993;46-54.
3. Joel D., Slatkin D., Fairchild R., Micca P., Nawrocky M. Pharmacokinetics and tissue distribution of the sulfhydryl boranes (monomers and dimer) in glioma-bearing rats. Strahlenther. Onkol. 165:1989;167-170.
4. Kraft S.L., Gavin P.R., Leathers C.W., DeHann C.E., Bauer W.F., Miller D.L., Dorn R.W., Griebenow M.L. Biodistribution of boron in dogs with spontaneous intracranial tumors following borocaptate administration. Cancer Res. 54:1994;1259-1263.
5. Mehta S.C., Boudinot F.D., Lu D.R. Pharmacokinetics of sodium mercaptoundecahydrododecaborate after intravenous injection in rats. Drug. Metab. Disp. 23:1995;1368-1371.
6. 11SH (BSH) in patients with malignant glioma as precondition for boron neutron capture therapy (BNCT). Int. J. Radiat. Oncol. Biol. Phys. 28:1994;1175-1181.
7. Stragliotto G., Fankhauser H. Biodistribution of boron sulfhydryl for boron neutron capture therapy in patients with intracranial tumors. Neurosurgery. 36:1995;285-293.
8. 11SH in patients with glioblastoma . Cancer Res. 54:1994;6318-6320.
9. Burian J., Janků I., Kvítek J., Mareš V., Prouza Z., Spurný F., Šourek K., Štíbr B., Štrouf O. BNCT project in Czechoslovakia. Fairchild R.G., Bond V.P., Woodhead W.D. Clinical aspects of neutron capture therapy. 1989;39 Plenum Press, New York.
10. Šourek K., Tovaryš F. Perspectives of the clinical BNCT of malignant gliomas in Czechoslovakia. Strahlenther. Onkol. 165:1989;247-249.
11. Dewit, L.; Mijnheer, B.; Moss, R.; Gabel, D. A proposal for clinical pilot studies for BNCT. In: Abstracts of the Fourth International Symposium on Neutron Capture Therapy for Cancer, 1990:167.
12. Janků I., Buchar E., Jiřička Z. Nephrotoxicity of borocaptate after short-term administration in rabbits. Toxicology. 79:1993;99-108.
13. Štrouf O., Mertenová E., Schneiderová L., Zámečníková H., Janků I. Boron determination for neutron capture therapy by colorimetry and emission spectrometry. Strahlenther. Onkol. 165:1989;174-176.
14. Soloway A.H., Messer J.R. Detection of hydrolytically stable hydrides in biological materials. Anal. Chem. 36:1964;433-434.
15. Horn V., Slánský J., Buchar E., Janků I., Šourek K., Tovaryš F. The diuretic effect of borocaptate sodium in rats and in patients with brain tumors. Methods Find. Exp. Clin. Pharmacol. 19:1997;559-566.
16. Saris S. Comment to the paper of G. Stragliotto and H. Fankhauser Biodistribution of boron sulfhydryl for boron neutron capture therapy in patients with intracranial tumors . Neurosurgery. 16:1995;293.
17. Abou-Shakra F.R., Havercroft J.M., Ward N.I. Lithium and boron in biological tissues and fluids. Trace Elements Med. 6:1989;142-146.
18. Ludden T.M., Beal S.L., Sheiner L.B. Comparison of the Akaike information criterion, the Schwartz criterion and the F test as guides to model selection. J. Pharmacokin. Biopharm. 22:1994;431-445.
19. Stragliotto, G. Biodistribution and pharmacokinetics of boron sulfhydryl for boron neutron capture therapy in patients with intracranial tumours. Thesis, Faculté de Médecine de l Université de Lausanne, 1993.
20. Sweet W.H., Messer J.R., Hatanaka H. Supplementary pharmacological study between 1972 and 1977 on purified mercaptoundecahydrododecaborate. Hatanaka H. Boron neutron capture therapy for tumors. 1986;59-76 Nishimura, Niigata.
21. Nakagawa T., Nagai T. Interaction between serum albumin and mercaptoundecahydrododecaborate ion (an agent for boron neutron capture therapy of brain tumor). Chem. Pharm. Bull. Tokyo. 24:1976;2934-2948.
22. 11SH impurities and metabolites. Strahlenther. Onkol. 165:1989;140-141.
23. Soloway A.H., Hatanaka H., Davis M.A. Penetration of brain and brain tumor. VII Tumor-binding sulfhydryl boron compounds . J. Med. Chem. 10:1967;714-717.
24. 11B nuclear magnetic resonance studies of the interaction of borocaptate sodium with serum albumin. Biochem. Pharmacol. 49:1995;625-632.
25. Soloway A.H., Alam F., Barth R.F., Bapat B.V. Boron chemistry and target cell affinity. Strahlenther. Onkol. 165:1989;118-120.
26. Mehta S.C., Lu D.R. Interspecies pharmacokinetic scaling of BSH in mice, rats, rabbits, and humans. Biopharm. Drug. Disp. 16:1995;735-744.
27. Stragliotto G., Munafo A., Biollaz J., Fankhauser H. Pharmacokinetics of boron sulfhydryl (BSH) in patients with intracranial tumours. Allen B.J., et al. Progress in neutron capture therapy for cancer. 1992;549-550 Plenum Press, New York.
28. Asbury A.K., Ojeman R.G., Nielsen S.L., Sweet W.H. Neuropathologic study of fourteen cases of malignant brain tumor treated by boron-10 slow neutron capture therapy. J. Neuropathol. Exp. Neurol. 31:1972;278-303.
29. Gabel, D. Minutes of the meeting of the Project Management Group Lausanne. In: Newsletter of the European Collaboration on Boron Neutron Capture Therapy of Tumors. 12:2-3; 1992.